# Congenital Athymia Patient Registry

> **NCT05329935** · — · RECRUITING · sponsor: **Sumitomo Pharma Switzerland GmbH** · enrollment: 75 (estimated)

## Conditions studied

- Complete DiGeorge Anomaly
- Complete DiGeorge Syndrome
- Congenital Athymia

## Interventions

- **BIOLOGICAL:** Cultured Thymus Tissue

## Key facts

- **NCT ID:** NCT05329935
- **Lead sponsor:** Sumitomo Pharma Switzerland GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-05-25
- **Primary completion:** 2026-04
- **Final completion:** 2026-04
- **Target enrollment:** 75 (ESTIMATED)
- **Last updated:** 2025-08-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05329935

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05329935, "Congenital Athymia Patient Registry". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05329935. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*